PitchBook News - What we expect in 2024

Our 8 analyst outlooks across US venture capital, private equity, healthcare, emerging technologies, European private capital, and the LP perspective.
Read online | Don't want to receive these emails? Manage your subscription.
PitchBook
Log in
The Research Pitch
December 23, 2023
Controlled-environment agriculture: Continuing our series on Emerging Sustainable Investment Opportunities, our new research dives into the potential across indoor farming, vertical farming, and more. Read it here.

We're hiring! If you or anyone in your network are looking for research or news opportunities, check out these new job postings out of our New York office:
 
What does 2024 hold for emerging tech?
Two mega-trends stand out in our 2024 emerging tech outlooks—the continued rise of AI and increasing M&A.

Our analysts pinpoint where AI is likely to have the greatest impact, as we expect significant advancements in automating labor-intensive activities such as farm work and driving in 2024 and 2025.

We also expect AI to further automate enterprise software applications by minimizing the need for human labor. These shifts should accelerate or sustain as AI models improve on the back of immense VC investment.

The second major trend we expect in 2024 is an increase in M&A in fintech, insurtech, identity and access management, and more.

The prospects of declining interest rates are boosting equity valuations and improving LBO math, both of which make M&A more likely. Additionally, decreasing odds of a recession are likely to push more large corporates to accelerate acquisitions in fintech, insurtech, cybersecurity, and SaaS.

Other key trends in our 2024 outlooks include greater institutional adoption and control of crypto assets, AI-driven improvements in personalized nutrition, greater penetration of drone deliveries, the shift to low/no carbon energy, increasing demand for carbon credits, and more adoption of composable e-commerce services.

Read all of our tech outlooks here:

Consumer Tech Outlook

Industrial Tech Outlook

Enterprise Tech Outlook
 
Thanks,

James Ulan
Lead Analyst, Emerging Technology
X (formerly Twitter) | LinkedIn
Share: Email LinkedIn Twitter Facebook
The road ahead for LPs and their private market allocations
Inflation is falling, public markets are near highs, and the economy is chugging along; US investors have plenty to celebrate this holiday season.

In stark contrast to sentiment at the start of the year, expectations of a soft landing for the US economy have risen considerably, providing encouraging signs for 2024's outlook. Still, a relatively higher rate environment appears to be here to stay, and private market allocations are under considerable scrutiny as investors weigh private assets' prospects going forward.

The slow exit environment has crimped cash flows from buyout and venture funds even while valuations remain elevated. Commercial real estate appears to be in the midst of a sharp correction. And questions have risen pertaining to private credit's ability to generate outsized returns sustainably.

In our 2024 Allocator Outlook, we explore these recent developments, potential economic scenarios going forward, and their impact on private markets.

With an eye on private asset valuations, relative attractiveness to public alternatives, and the supply of capital, our outlook provides capital allocators a framework to evaluate the risks and opportunities across their private markets portfolio.

Download our free Allocator Outlook.
 
Best regards,

Zane Carmean, CFA, CAIA
Lead Analyst, Quantitative and Funds Research
Share: Email LinkedIn Twitter Facebook
 
More Outlooks  

2024 Healthcare Outlook

Burned by cost inflation and negative reimbursement trends, US health systems are beleaguered.

At the same time, healthcare investors have been spooked by some high-profile failed bets in biopharma.

Our 2024 Healthcare Outlook predicts that both forces will have a depressing effect on healthcare deals in both VC and PE—with possible exceptions for AI and anti-obesity drug companies.

Other topics covered include surgical robots, generative AI, and value-based care consolidation.

2024 US Private Equity Outlook

After a year characterized by a slowdown in dealmaking and fundraising, our analysts shared expectations for 2024 in their US Private Equity Outlook:
  • There is likely to be a substantial amount of new continuation funds as PE managers navigate a challenging exit landscape.

  • Fundraising overall may slide in the face of slower distributions.

  • Technology-focused funds are expected to outperform their generalist peers as the sector is buoyed by its resilient fundamentals and improving company valuations.

2024 US Venture Capital Outlook

Our analysts see moderate improvement on the horizon for the VC ecosystem on the back of economic strength and signals of easing rates.

Dive into our US Venture Capital Outlook for more:
  • Expect VC fundraising to increase slightly over 2023 yet continue to fall short of recent years.

  • We forecast nontraditional investors will reenter the asset class, giving some relief to VCs supporting portfolio companies.

  • The number of unicorns and their collective valuation is set to decline as more are forced to raise capital.

2024 European Private Capital Outlook

Economic uncertainty weighed on European PE and VC activity this year, but will the prospect of greater interest rate stability and improved market confidence bring a change of fortunes in 2024?

Read our analysts' predictions in our European Private Capital Outlook, including:
  • PE fundraising is expected to become even more concentrated in the region's biggest funds.

  • PE mega-deals will likely remain muted.

  • A recovery in VC-backed IPOs is unlikely, but there is hope for VC fundraising.
 
Thematic Research  

Prime Time for Software

We're far from the heydays of the pandemic lockdown-induced software boom, but conditions are ripe for another strong run by PE-backed software companies.

Software providers' margins are up, tech deal counts are better than pre-pandemic levels, and SaaS business models remain compelling.
 
Despite a tough year, we estimate $164 billion in dry powder for tech-focused PE firms.

As the portfolios of Thoma Bravo and Vista Equity Partners bring in revenues rivaling top software corporations, our analysts dive deep into PE activity in tech:
read the free research
 
 
Webinars & Events  

PitchBook at JPM 2024

Join us! Our healthcare analyst team will be on-site in San Francisco for the J.P. Morgan Healthcare Conference, which runs from Jan. 8-11.

For PitchBook clients, we're hosting an investor lounge on Jan. 9 where you can network, recharge, refuel, and connect with our analysts for in-person discussions around healthcare services and digital health. More details here.

We're also hosting a pair of free webinars:

Jan. 9: Though multiple biotech subindustries showed promise, setbacks have pushed VC toward new therapeutic applications. Our analyst Kazi Helal will discuss it all with a panel of VC biotech investors. Register here.

Jan. 11: Our team will recap JPM 2024 and share our most important takeaways from the private company-related presentations and discussions. Register here.
 
 
In the News  

Our insights and data featured in the press:
  • Why consumer spending needs to stay strong for 2024's leading IPO candidates. [Yahoo Finance]

  • The value-based care enablement wave is coming. [Axios Pro]

  • What do rising token prices mean for VC activity in crypto? Our tech analyst Robert Le discussed that and other topics on Crypto World. [CNBC]

  • Why US PE middle market fundraising has been down. [WSJ Pro]

  • The key factor that has the commercial drone delivery market at a tipping point. [Yahoo Finance]
If you're a journalist interested in interviewing our analysts or requesting data, contact our PR team.
 
 
ICYMI  

More of our recent research (* - report preview):

Market updates
Thematic research
Industry & tech research
Credit research
Coming next week (subject to change)
  • A recap of our best research this year
 

Thanks for reading! Feel free to email us any time with feedback, questions, or tips!

Learn more about the PitchBook Institutional Research Group, meet our analysts, or access our research libraries for clients and non-clients.

Did someone forward this newsletter to you? Sign up at pitchbook.com/subscribe.
 
 
Since yesterday, the PitchBook Platform added:
10
VC valuations
1653
People
580
Companies
36
Funds
See what our data software can do
 
About PitchBook | Terms of use | Advertise with us | Contact
Follow us: in twtr fb

This email was sent to you via the PitchBook Platform.

Do you want to change your email address, get a different edition or unsubscribe? Manage your subscription here.

© 2023 PitchBook. Win what's next. All rights reserved.

Older messages

Visions for enterprise, consumer tech in 2024

Friday, December 22, 2023

Biopharma VCs zero in on gene therapy; PE exit troubles hit the mid-market; Vestwell inks $125M Series D Read online | Don't want to receive these emails? Manage your subscription. Log in The Daily

Many VCs have stopped writing checks

Thursday, December 21, 2023

Trends to watch in Europe for 2024; sustainable investing opportunites in indoor farming; Sudo Biosciences takes home $116M Series B Read online | Don't want to receive these emails? Manage your

Emerging industrial tech's outlook for 2024

Wednesday, December 20, 2023

How startup verticals fared in 2023; the surge for software is just beginning; PE predictions focus on funds for 2024 Read online | Don't want to receive these emails? Manage your subscription. Log

Analysts make VC 2024 predictions

Tuesday, December 19, 2023

GenAI ready to disrupt healthcare in 2024; will Adobe-Figma failure cool M&A in VC?; Tamara nabs unicorn status with $340M Series C Read online | Don't want to receive these emails? Manage your

A new year for allocators

Monday, December 18, 2023

It's prime time for software; Accel secures $650M for outsize fund; the Amazon trickle-down effect; the most active investors in supply chain tech Read online | Don't want to receive these

You Might Also Like

GPT o1 vs. 4o 🥊, Accelerator List 🚀, AI Coming To Your Ads 🤖, and Game-Changing AI Guides 🧭

Thursday, September 19, 2024

Plus: CRO Hacks 📋, B2B Gems 💎, UX Mockup Tutorial Using AI 🎨, Elevator Pitch Tips 🎤, and more! ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

FREE AI training for marketers…

Thursday, September 19, 2024

Hi Reader, Do you know you need to do more with AI? If so, I've got some high-quality video training for you. It's designed by me. And for a limited time, it's free. GET ACCESS TODAY I can

Exciting announcement

Thursday, September 19, 2024

I've got an announcement just for you: Our master class series last year had a 99% satisfaction rate. Several people have emailed me asking for a repeat of the experience this year... So, we're

📣 Now open: free registration for Litmus Live, SEO for email, and more

Thursday, September 19, 2024

The latest email resources from the Litmus blog and a few of our favorite things from around the web last week. ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌

Discover the new Digiday Streaming and Video Awards categories

Thursday, September 19, 2024

Showcase how your company is modernizing streaming and video ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Fed Begins Easing Cycle with Jumbo 50bps Rate Cut

Thursday, September 19, 2024

Plus House Committee Questions SEC's Crypto Strategy in Divisive Hearing ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

[Webinar] 👀 Unlock lululemon’s winning social media formula

Thursday, September 19, 2024

Join us for an exclusive peek on October 1! ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

🦄 The GTM coach for 12 unicorns

Thursday, September 19, 2024

An interview with Scott Leese, Founder and CEO of Scott Leese Consulting. 🤝 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

✅ The Forbes Parasite SEO Playbook

Thursday, September 19, 2024

GM nerds, Welcome back to the newsletter that makes it make sense: ​ TLDR; favoritism, corruption, incompetence, etc. More on this later, but here's what's good this week: → Meta's New AI-

HubSpot and Shopify Are Both Going More Enterprise

Thursday, September 19, 2024

But Also — More SMB. To view this email as a web page, click here saastr daily newsletter HubSpot and Shopify Are Both Going More Enterprise. But Also — More SMB. By Jason Lemkin Tuesday, September 17,